Atlas Trials

Advanced Refractory Solid Tumors

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Refractory Solid Tumors

RecordFirmDate
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0) (NCT04892498)Second Affiliated Hospital of Soochow University2021-05-30
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START) (NCT05035745)National University Hospital, Singapore2021-03-01
Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors (NCT04685473)Taivex Therapeutics Corporation2021-01-07
A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors (NCT04200404)CStone Pharmaceuticals2019-12-13
Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (NCT04324372)Sunshine Lake Pharma Co., Ltd.2019-02-27
An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03349073)Taivex Therapeutics Corporation2017-09-14
Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03195764)Taivex Therapeutics Corporation2017-09-14
NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors (NCT02300467)National OncoVenture2014-12-01
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors (NCT01779336)Piramal Enterprises Limited2012-12-01
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors (NCT01762410)Piramal Enterprises Limited2012-09-01

Track Advanced Refractory Solid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.